ATE490341T1 - Diagnostika und therapeutika für mit einem entzündlichen il-1-haplotyp assoziierte krankheiten - Google Patents
Diagnostika und therapeutika für mit einem entzündlichen il-1-haplotyp assoziierte krankheitenInfo
- Publication number
- ATE490341T1 ATE490341T1 AT05744466T AT05744466T ATE490341T1 AT E490341 T1 ATE490341 T1 AT E490341T1 AT 05744466 T AT05744466 T AT 05744466T AT 05744466 T AT05744466 T AT 05744466T AT E490341 T1 ATE490341 T1 AT E490341T1
- Authority
- AT
- Austria
- Prior art keywords
- haplotype
- diagnostics
- inflammatory
- diseases associated
- therapeutic media
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56772704P | 2004-05-03 | 2004-05-03 | |
PCT/US2005/015267 WO2005108619A2 (en) | 2004-05-03 | 2005-05-03 | Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE490341T1 true ATE490341T1 (de) | 2010-12-15 |
Family
ID=35106680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05744466T ATE490341T1 (de) | 2004-05-03 | 2005-05-03 | Diagnostika und therapeutika für mit einem entzündlichen il-1-haplotyp assoziierte krankheiten |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1751304B1 (de) |
AT (1) | ATE490341T1 (de) |
CA (1) | CA2565562A1 (de) |
DE (1) | DE602005025111D1 (de) |
ES (1) | ES2356167T3 (de) |
WO (1) | WO2005108619A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7820383B2 (en) | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
US8105775B2 (en) | 2005-10-25 | 2012-01-31 | Interleukin Genetics, Inc. | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
ES2431671T3 (es) * | 2006-11-15 | 2013-11-27 | Interleukin Genetics, Inc. | El complejo génico de IL-1 y resistencia a la insulina: polimorfismos asociados, haplotipos y métodos para usarlos |
BR112012007399A2 (pt) * | 2009-09-29 | 2016-08-09 | United Technologies Ut Ag | composição de cuidado oral, usos da interleucina-1 recombinante humana e métodos para reduzir o mau hálito e para o tratamento ou prevenção de doença periodontal. |
AU2011338210B2 (en) * | 2010-12-09 | 2016-05-12 | Orig3N, Inc. | Improved method and kit for determining severity and progression of periodontal disease |
RU2469737C1 (ru) * | 2011-06-28 | 2012-12-20 | Федеральное государственное учреждение "Санкт-Петербургский научно-исследовательский институт уха, горла, носа и речи" Министерства здравоохранения и социального развития России (СПб НИИ ЛОР МИНЗДРАВСОЦРАЗВИТИЯ РОССИИ) | Способ лечения хронического риносинусита |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2450809A1 (en) * | 2001-06-15 | 2002-12-27 | Interleukin Genetics, Inc. | Methods for detecting and treating the early onset of aging-related conditions |
JP4492849B2 (ja) * | 2001-11-19 | 2010-06-30 | インターリューキン ジェネティックス インコーポレイテッド | 転写および炎症性疾患および感染症に対する感受性に影響するインターロイキン−1遺伝子座の機能的多型 |
-
2005
- 2005-05-03 WO PCT/US2005/015267 patent/WO2005108619A2/en active Application Filing
- 2005-05-03 EP EP05744466A patent/EP1751304B1/de not_active Not-in-force
- 2005-05-03 DE DE602005025111T patent/DE602005025111D1/de active Active
- 2005-05-03 CA CA002565562A patent/CA2565562A1/en not_active Abandoned
- 2005-05-03 ES ES05744466T patent/ES2356167T3/es active Active
- 2005-05-03 AT AT05744466T patent/ATE490341T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1751304A2 (de) | 2007-02-14 |
EP1751304B1 (de) | 2010-12-01 |
WO2005108619A3 (en) | 2006-04-27 |
WO2005108619A2 (en) | 2005-11-17 |
ES2356167T3 (es) | 2011-04-05 |
DE602005025111D1 (de) | 2011-01-13 |
CA2565562A1 (en) | 2005-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Massart et al. | Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells | |
ATE490341T1 (de) | Diagnostika und therapeutika für mit einem entzündlichen il-1-haplotyp assoziierte krankheiten | |
ATE520988T1 (de) | Verfahren und zusammensetzungen zur bewertung einer brustkrebsprognose | |
Fetahu et al. | Epigenetic signatures of methylated DNA cytosine in Alzheimer’s disease | |
Kordi-Tamandani et al. | Analysis of association between dopamine receptor genes’ methylation and their expression profile with the risk of schizophrenia | |
MY150234A (en) | Predictive markers for ovarian cancer | |
Agarwal et al. | Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum | |
ATE525397T1 (de) | Antikörpermoleküle mit spezifität für humanes il- 1 beta | |
ATE462710T1 (de) | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert | |
Miller et al. | The retinoid-related orphan receptor alpha (RORA) gene and fear-related psychopathology | |
DE602006018578D1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
CY1110252T1 (el) | Μεθοδος για την προβλεψη, διαγνωση και διαφορικη διαγνωση της νοσου του αλτζχαιμερ | |
ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
BRPI0519570A2 (pt) | mÉtodo de determinaÇço de faixa de dose de uma warfarina para um indivÍduo, kit para determinaÇço da faixa de dose de uma warfarina, oligonucleotÍdeo ou complemento do mesmo, e, arranjo de oligonucleotÍdeos | |
Al-Mahdawi et al. | Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus | |
Schnurbein et al. | RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families | |
BRPI0819018A2 (pt) | "métodos para determinar se um paciente possui risco aumentado de desenvolver hipertensão, para determinar se um paciente possui maior probalidade de se beneficiar do tratamento com um antagonista de vegf e kits para determinar se um paciente possui risco aumentado de desenvolver hipertensão e para determinar se um paciente possui maior probabilidade de se beneficiar do tratamento com um antagonista de vegf" | |
Maffioletti et al. | miR-146a plasma levels are not altered in Alzheimer’s disease but correlate with age and illness severity | |
HRP20150948T1 (hr) | Biomarkeri za procjenjivanje perifernog neuropatskog odgovora na lijeäśenje sa inhibitorom proteazoma | |
ATE474857T1 (de) | Antikörper gegen ein epitop auf agr2, assays und hybridome | |
Wu et al. | Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults | |
Saber et al. | Lack of acute phase response in the livers of mice exposed to diesel exhaust particles or carbon black by inhalation | |
Glorioso et al. | Rate of brain aging and APOE ε4 are synergistic risk factors for Alzheimer’s disease | |
Harris et al. | Heterozygosity for nuclear factor one x affects hippocampal-dependent behaviour in mice | |
McCreary et al. | The rat cumulative allostatic load measure (rCALM): a new translational assessment of the burden of stress |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |